NTNU – Norwegian University of Science and Technology

NTNU Colourlab

Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

6,291 to 6,300 of 6,570 Results

qmigrant_responses.txt Jun 16, 2020 - Replication Data for: Diskriminering og sosial ekskludering av skeive med innvandrerbakgrunn Plain Text - 349.8 KB - MD5: e1a894fbe46b7828b86e9da877164cfb Response data set
01_3_NINA-1_SPIRIT2013_33_item_checklist.pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 100.2 KB - MD5: 5225602d1b3fdff2f18a9189a37b8db6 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT 2013) This statement provides evidence for the minimum content of the NINA-1 trial protocol as outlined by SPIRIT
02_NINA-1_IB_version_7_March2020.pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 1.1 MB - MD5: b7b54792d295074da50ddc8a6c820739 INVESTIGATOR’S BROCHURE PRODUCT: Nalokson DnE Nasal Spray 14 mg/mL
05_3_NINA-1_Financing_Contract_NTNU_FarmaIndusriAS.pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 971.7 KB - MD5: 3448326f647098679153a61679819f99 Agreements between NTNU and Farma Industri governing the funding of Study Medicine and ensuring NTNU full ownership of trial results.
05_3_NINA-1_Financing_Regional_Health_Authority(EN_NO).pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 3.3 MB - MD5: a95cf2d72d1dfc324e125ab8dcba0430 Financing for PhD position for Arne Skulberg supervised by Prof. Ola Dale and main funding for NINA-1
06_1_NINA-1_National_Ethics_Approval_March_2017_(EN_NO).pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 7.8 MB - MD5: ea3a92eae5a70cf98e2cfe42711db753 Trial approval and review by The National Committee for Medical and Health Research Ethics (NEM) in Norway
06_1_NINA-1_Regional_Ethics_Approval_March_2020(EN_NO).pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 1.0 MB - MD5: b30e40d8eb4857663520f6a8324ea060 Approval of protocol version 3.3 06. March 2020 by The Regional Committee for Medical and Health Research Ethics (REC) in Norway
06_1_NINA-1_Regional_Ethics_Approval_Oct_2017(EN_NO).pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 3.2 MB - MD5: 8b4cd65e220676bfb371089df4dd65d4 Approval of protocol NINA-1 trial by The Regional Committee for Medical and Health Research Ethics (REC) in Norway
06_2_NINA-1_First_trial_approval_NoMA_December_2017.pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 215.7 KB - MD5: 8b31c095c16a2690bb775cdaafc2e6f2 Original approval by The Norwegian Medicines Agency
06_2_NINA-1_Protocol_v_3_3_approval_NoMA_March_2020.pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 155.9 KB - MD5: 90cf357930d8ea3bd0161b7b9c63acb4 Approval by Norwegian Medicines Agency protocol amendments version 3.3 dated 6th March 2020

qmigrant_responses.txt

Jun 16, 2020 - Replication Data for: Diskriminering og sosial ekskludering av skeive med innvandrerbakgrunn

Plain Text - 349.8 KB -

Response data set

01_3_NINA-1_SPIRIT2013_33_item_checklist.pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 100.2 KB -

Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT 2013) This statement provides evidence for the minimum content of the NINA-1 trial protocol as outlined by SPIRIT

02_NINA-1_IB_version_7_March2020.pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 1.1 MB -

INVESTIGATOR’S BROCHURE PRODUCT: Nalokson DnE Nasal Spray 14 mg/mL

05_3_NINA-1_Financing_Contract_NTNU_FarmaIndusriAS.pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 971.7 KB -

Agreements between NTNU and Farma Industri governing the funding of Study Medicine and ensuring NTNU full ownership of trial results.

05_3_NINA-1_Financing_Regional_Health_Authority(EN_NO).pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 3.3 MB -

Financing for PhD position for Arne Skulberg supervised by Prof. Ola Dale and main funding for NINA-1

06_1_NINA-1_National_Ethics_Approval_March_2017_(EN_NO).pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 7.8 MB -

Trial approval and review by The National Committee for Medical and Health Research Ethics (NEM) in Norway

06_1_NINA-1_Regional_Ethics_Approval_March_2020(EN_NO).pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 1.0 MB -

Approval of protocol version 3.3 06. March 2020 by The Regional Committee for Medical and Health Research Ethics (REC) in Norway

06_1_NINA-1_Regional_Ethics_Approval_Oct_2017(EN_NO).pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 3.2 MB -

Approval of protocol NINA-1 trial by The Regional Committee for Medical and Health Research Ethics (REC) in Norway

06_2_NINA-1_First_trial_approval_NoMA_December_2017.pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 215.7 KB -

Original approval by The Norwegian Medicines Agency

06_2_NINA-1_Protocol_v_3_3_approval_NoMA_March_2020.pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 155.9 KB -

Approval by Norwegian Medicines Agency protocol amendments version 3.3 dated 6th March 2020

Add Data

Share Dataverse

Link Dataverse

Reset Modifications